Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating Cryoablation of Metastatic Lung/Pleura Tumors in Patients - Safety and Efficacy

NCT01307501 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.

NCT NCT01307501
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01307501 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating Cryoablation of Metastatic Lung/Pleura Tumors in Patients - Safety and Efficacy
Lead sponsor
Boston Scientific Corporation
Phase
Not applicable
Overall status
Completed
Start date
January 4, 2012
Completion date
August 30, 2018
Enrollment
40 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic lung cancer